 | • レポートコード：QAF27559 • 出版社/出版日：QYResearch / 2021年4月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の制酸剤市場について種類別（プロトンポンプ阻害剤、H2拮抗薬、酸中和剤）、用途別（OTC薬、Rx薬）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・制酸剤市場の概要 ・世界の主要地域別制酸剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の制酸剤市場規模2016-2021：種類別（プロトンポンプ阻害剤、H2拮抗薬、酸中和剤） ・世界の制酸剤市場予測2012-2027：種類別（プロトンポンプ阻害剤、H2拮抗薬、酸中和剤） ・世界の制酸剤市場規模2016-2021：用途別（OTC薬、Rx薬） ・世界の制酸剤市場予測2012-2027：用途別（OTC薬、Rx薬） ・制酸剤のアメリカ市場規模と予測2016-2021 ・制酸剤のヨーロッパ市場規模と予測2016-2021 ・制酸剤の中国市場規模と予測2016-2021 ・制酸剤の日本市場規模と予測2016-2021 ・制酸剤の東南アジア市場規模と予測2016-2021 ・制酸剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca、Takeda Pharmaceutical、Pfizer、Reckitt Benckiser、Bayer、Procter＆Gamble、GlaxoSmithKline、Johnson＆Johnson、CONBA、Xiuzheng Pharma、Sanofi、Bausch Health、CR SANJIU、Reddy's Laboratories） ・制酸剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・制酸剤の市場動向・機会・課題 ・調査の結論 |
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they’re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.
The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Antacid Market
The global Antacid market was valued at US$ 6329.7 in 2020 and will reach US$ 6639.7 million by the end of 2027, growing at a CAGR of 0.8% during 2022-2027.
Global Antacid Scope and Market Size
The global Antacid market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antacid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Segment by Application
OTC Drug
Rx Drug
The Antacid market is analysed and market size information is provided by regions (countries). Segment by Application, the Antacid market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy’s Laboratories
1 Antacid Market Overview
1.1 Antacid Product Scope
1.2 Antacid Segment by Type
1.2.1 Global Antacid Sales by Type (2016 & 2021 & 2027)
1.2.2 Proton Pump Inhibitor
1.2.3 H2 Antagonist
1.2.4 Acid Neutralizers
1.3 Antacid Segment by Application
1.3.1 Global Antacid Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 OTC Drug
1.3.3 Rx Drug
1.4 Antacid Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antacid Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antacid Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antacid Price Trends (2016-2027)
2 Antacid Estimates and Forecasts by Region
2.1 Global Antacid Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antacid Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antacid Sales Market Share by Region (2016-2021)
2.2.2 Global Antacid Revenue Market Share by Region (2016-2021)
2.3 Global Antacid Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antacid Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antacid Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antacid Estimates and Projections (2016-2027)
2.4.2 Europe Antacid Estimates and Projections (2016-2027)
2.4.3 China Antacid Estimates and Projections (2016-2027)
2.4.4 Japan Antacid Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antacid Estimates and Projections (2016-2027)
2.4.6 India Antacid Estimates and Projections (2016-2027)
3 Global Antacid Competition Landscape by Players
3.1 Global Top Antacid Players by Sales (2016-2021)
3.2 Global Top Antacid Players by Revenue (2016-2021)
3.3 Global Antacid Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antacid as of 2020)
3.4 Global Antacid Average Price by Company (2016-2021)
3.5 Manufacturers Antacid Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antacid Market Size by Type
4.1 Global Antacid Historic Market Review by Type (2016-2021)
4.1.1 Global Antacid Sales Market Share by Type (2016-2021)
4.1.2 Global Antacid Revenue Market Share by Type (2016-2021)
4.1.3 Global Antacid Price by Type (2016-2021)
4.2 Global Antacid Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antacid Sales Forecast by Type (2022-2027)
4.2.2 Global Antacid Revenue Forecast by Type (2022-2027)
4.2.3 Global Antacid Price Forecast by Type (2022-2027)
5 Global Antacid Market Size by Application
5.1 Global Antacid Historic Market Review by Application (2016-2021)
5.1.1 Global Antacid Sales Market Share by Application (2016-2021)
5.1.2 Global Antacid Revenue Market Share by Application (2016-2021)
5.1.3 Global Antacid Price by Application (2016-2021)
5.2 Global Antacid Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antacid Sales Forecast by Application (2022-2027)
5.2.2 Global Antacid Revenue Forecast by Application (2022-2027)
5.2.3 Global Antacid Price Forecast by Application (2022-2027)
6 North America Antacid Market Facts & Figures
6.1 North America Antacid Sales by Company
6.1.1 North America Antacid Sales by Company (2016-2021)
6.1.2 North America Antacid Revenue by Company (2016-2021)
6.2 North America Antacid Sales Breakdown by Type
6.2.1 North America Antacid Sales Breakdown by Type (2016-2021)
6.2.2 North America Antacid Sales Breakdown by Type (2022-2027)
6.3 North America Antacid Sales Breakdown by Application
6.3.1 North America Antacid Sales Breakdown by Application (2016-2021)
6.3.2 North America Antacid Sales Breakdown by Application (2022-2027)
7 Europe Antacid Market Facts & Figures
7.1 Europe Antacid Sales by Company
7.1.1 Europe Antacid Sales by Company (2016-2021)
7.1.2 Europe Antacid Revenue by Company (2016-2021)
7.2 Europe Antacid Sales Breakdown by Type
7.2.1 Europe Antacid Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antacid Sales Breakdown by Type (2022-2027)
7.3 Europe Antacid Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Antacid Market Facts & Figures
8.1 China Antacid Sales by Company
8.1.1 China Antacid Sales by Company (2016-2021)
8.1.2 China Antacid Revenue by Company (2016-2021)
8.2 China Antacid Sales Breakdown by Type
8.2.1 China Antacid Sales Breakdown by Type (2016-2021)
8.2.2 China Antacid Sales Breakdown by Type (2022-2027)
8.3 China Antacid Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Antacid Market Facts & Figures
9.1 Japan Antacid Sales by Company
9.1.1 Japan Antacid Sales by Company (2016-2021)
9.1.2 Japan Antacid Revenue by Company (2016-2021)
9.2 Japan Antacid Sales Breakdown by Type
9.2.1 Japan Antacid Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antacid Sales Breakdown by Type (2022-2027)
9.3 Japan Antacid Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antacid Market Facts & Figures
10.1 Southeast Asia Antacid Sales by Company
10.1.1 Southeast Asia Antacid Sales by Company (2016-2021)
10.1.2 Southeast Asia Antacid Revenue by Company (2016-2021)
10.2 Southeast Asia Antacid Sales Breakdown by Type
10.2.1 Southeast Asia Antacid Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antacid Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antacid Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Antacid Market Facts & Figures
11.1 India Antacid Sales by Company
11.1.1 India Antacid Sales by Company (2016-2021)
11.1.2 India Antacid Revenue by Company (2016-2021)
11.2 India Antacid Sales Breakdown by Type
11.2.1 India Antacid Sales Breakdown by Type (2016-2021)
11.2.2 India Antacid Sales Breakdown by Type (2022-2027)
11.3 India Antacid Sales Breakdown by Application
11.3.1 India Antacid Sales Breakdown by Application (2016-2021)
11.3.2 India Antacid Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antacid Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Antacid Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Antacid Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Takeda Pharmaceutical
12.2.1 Takeda Pharmaceutical Corporation Information
12.2.2 Takeda Pharmaceutical Business Overview
12.2.3 Takeda Pharmaceutical Antacid Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Pharmaceutical Antacid Products Offered
12.2.5 Takeda Pharmaceutical Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Antacid Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Antacid Products Offered
12.3.5 Pfizer Recent Development
12.4 Reckitt Benckiser
12.4.1 Reckitt Benckiser Corporation Information
12.4.2 Reckitt Benckiser Business Overview
12.4.3 Reckitt Benckiser Antacid Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Reckitt Benckiser Antacid Products Offered
12.4.5 Reckitt Benckiser Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Antacid Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Antacid Products Offered
12.5.5 Bayer Recent Development
12.6 Procter＆Gamble
12.6.1 Procter＆Gamble Corporation Information
12.6.2 Procter＆Gamble Business Overview
12.6.3 Procter＆Gamble Antacid Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Procter＆Gamble Antacid Products Offered
12.6.5 Procter＆Gamble Recent Development
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Corporation Information
12.7.2 GlaxoSmithKline Business Overview
12.7.3 GlaxoSmithKline Antacid Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GlaxoSmithKline Antacid Products Offered
12.7.5 GlaxoSmithKline Recent Development
12.8 Johnson＆Johnson
12.8.1 Johnson＆Johnson Corporation Information
12.8.2 Johnson＆Johnson Business Overview
12.8.3 Johnson＆Johnson Antacid Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johnson＆Johnson Antacid Products Offered
12.8.5 Johnson＆Johnson Recent Development
12.9 CONBA
12.9.1 CONBA Corporation Information
12.9.2 CONBA Business Overview
12.9.3 CONBA Antacid Sales, Revenue and Gross Margin (2016-2021)
12.9.4 CONBA Antacid Products Offered
12.9.5 CONBA Recent Development
12.10 Xiuzheng Pharma
12.10.1 Xiuzheng Pharma Corporation Information
12.10.2 Xiuzheng Pharma Business Overview
12.10.3 Xiuzheng Pharma Antacid Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Xiuzheng Pharma Antacid Products Offered
12.10.5 Xiuzheng Pharma Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Business Overview
12.11.3 Sanofi Antacid Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi Antacid Products Offered
12.11.5 Sanofi Recent Development
12.12 Bausch Health
12.12.1 Bausch Health Corporation Information
12.12.2 Bausch Health Business Overview
12.12.3 Bausch Health Antacid Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bausch Health Antacid Products Offered
12.12.5 Bausch Health Recent Development
12.13 CR SANJIU
12.13.1 CR SANJIU Corporation Information
12.13.2 CR SANJIU Business Overview
12.13.3 CR SANJIU Antacid Sales, Revenue and Gross Margin (2016-2021)
12.13.4 CR SANJIU Antacid Products Offered
12.13.5 CR SANJIU Recent Development
12.14 Reddy’s Laboratories
12.14.1 Reddy’s Laboratories Corporation Information
12.14.2 Reddy’s Laboratories Business Overview
12.14.3 Reddy’s Laboratories Antacid Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Reddy’s Laboratories Antacid Products Offered
12.14.5 Reddy’s Laboratories Recent Development
13 Antacid Manufacturing Cost Analysis
13.1 Antacid Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antacid
13.4 Antacid Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antacid Distributors List
14.3 Antacid Customers
15 Market Dynamics
15.1 Antacid Market Trends
15.2 Antacid Drivers
15.3 Antacid Market Challenges
15.4 Antacid Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antacid Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antacid Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antacid Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antacid Sales (M Units) by Region (2016-2021)
Table 5. Global Antacid Sales Market Share by Region (2016-2021)
Table 6. Global Antacid Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antacid Revenue Share by Region (2016-2021)
Table 8. Global Antacid Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Antacid Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antacid Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antacid Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antacid Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Antacid Sales Share by Company (2016-2021)
Table 14. Global Antacid Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antacid Revenue Share by Company (2016-2021)
Table 16. Global Antacid by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antacid as of 2020)
Table 17. Global Antacid Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Antacid Manufacturing Sites and Area Served
Table 19. Manufacturers Antacid Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antacid Sales (M Units) by Type (2016-2021)
Table 22. Global Antacid Sales Share by Type (2016-2021)
Table 23. Global Antacid Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antacid Price (USD/Unit) by Type (2016-2021)
Table 25. Global Antacid Sales Share by Type (2022-2027)
Table 26. Global Antacid Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antacid Revenue Share by Type (2022-2027)
Table 28. Global Antacid Price (USD/Unit) by Type (2022-2027)
Table 29. Global Antacid Sales (M Units) by Application (2016-2021)
Table 30. Global Antacid Sales Share by Application (2016-2021)
Table 31. Global Antacid Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antacid Price (USD/Unit) by Application (2016-2021)
Table 33. Global Antacid Sales (M Units) by Application (2022-2027)
Table 34. Global Antacid Sales Share by Application (2022-2027)
Table 35. Global Antacid Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antacid Revenue Share by Application (2022-2027)
Table 37. Global Antacid Price (USD/Unit) by Application (2022-2027)
Table 38. North America Antacid Sales (M Units) by Company (2016-2021)
Table 39. North America Antacid Sales Market Share by Company (2016-2021)
Table 40. North America Antacid Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antacid Revenue Market Share by Company (2016-2021)
Table 42. North America Antacid Sales by Type (2016-2021) & (M Units)
Table 43. North America Antacid Sales Market Share by Type (2016-2021)
Table 44. North America Antacid Sales by Type (2022-2027) & (M Units)
Table 45. North America Antacid Sales Market Share by Type (2022-2027)
Table 46. North America Antacid Sales by Application (2016-2021) & (M Units)
Table 47. North America Antacid Sales Market Share by Application (2016-2021)
Table 48. North America Antacid Sales by Application (2022-2027) & (M Units)
Table 49. North America Antacid Sales Market Share by Application (2022-2027)
Table 50. Europe Antacid Sales (M Units) by Company (2016-2021)
Table 51. Europe Antacid Sales Market Share by Company (2016-2021)
Table 52. Europe Antacid Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antacid Revenue Market Share by Company (2016-2021)
Table 54. Europe Antacid Sales by Type (2016-2021) & (M Units)
Table 55. Europe Antacid Sales Market Share by Type (2016-2021)
Table 56. Europe Antacid Sales by Type (2022-2027) & (M Units)
Table 57. Europe Antacid Sales Market Share by Type (2022-2027)
Table 58. Europe Antacid Sales by Application (2016-2021) & (M Units)
Table 59. Europe Antacid Sales Market Share by Application (2016-2021)
Table 60. Europe Antacid Sales by Application (2022-2027) & (M Units)
Table 61. Europe Antacid Sales Market Share by Application (2022-2027)
Table 62. China Antacid Sales (M Units) by Company (2016-2021)
Table 63. China Antacid Sales Market Share by Company (2016-2021)
Table 64. China Antacid Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antacid Revenue Market Share by Company (2016-2021)
Table 66. China Antacid Sales by Type (2016-2021) & (M Units)
Table 67. China Antacid Sales Market Share by Type (2016-2021)
Table 68. China Antacid Sales by Type (2022-2027) & (M Units)
Table 69. China Antacid Sales Market Share by Type (2022-2027)
Table 70. China Antacid Sales by Application (2016-2021) & (M Units)
Table 71. China Antacid Sales Market Share by Application (2016-2021)
Table 72. China Antacid Sales by Application (2022-2027) & (M Units)
Table 73. China Antacid Sales Market Share by Application (2022-2027)
Table 74. Japan Antacid Sales (M Units) by Company (2016-2021)
Table 75. Japan Antacid Sales Market Share by Company (2016-2021)
Table 76. Japan Antacid Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antacid Revenue Market Share by Company (2016-2021)
Table 78. Japan Antacid Sales by Type (2016-2021) & (M Units)
Table 79. Japan Antacid Sales Market Share by Type (2016-2021)
Table 80. Japan Antacid Sales by Type (2022-2027) & (M Units)
Table 81. Japan Antacid Sales Market Share by Type (2022-2027)
Table 82. Japan Antacid Sales by Application (2016-2021) & (M Units)
Table 83. Japan Antacid Sales Market Share by Application (2016-2021)
Table 84. Japan Antacid Sales by Application (2022-2027) & (M Units)
Table 85. Japan Antacid Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antacid Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Antacid Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antacid Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antacid Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antacid Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Antacid Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antacid Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Antacid Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antacid Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Antacid Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antacid Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Antacid Sales Market Share by Application (2022-2027)
Table 98. India Antacid Sales (M Units) by Company (2016-2021)
Table 99. India Antacid Sales Market Share by Company (2016-2021)
Table 100. India Antacid Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antacid Revenue Market Share by Company (2016-2021)
Table 102. India Antacid Sales by Type (2016-2021) & (M Units)
Table 103. India Antacid Sales Market Share by Type (2016-2021)
Table 104. India Antacid Sales by Type (2022-2027) & (M Units)
Table 105. India Antacid Sales Market Share by Type (2022-2027)
Table 106. India Antacid Sales by Application (2016-2021) & (M Units)
Table 107. India Antacid Sales Market Share by Application (2016-2021)
Table 108. India Antacid Sales by Application (2022-2027) & (M Units)
Table 109. India Antacid Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. AstraZeneca Antacid Product
Table 114. AstraZeneca Recent Development
Table 115. Takeda Pharmaceutical Corporation Information
Table 116. Takeda Pharmaceutical Description and Business Overview
Table 117. Takeda Pharmaceutical Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Takeda Pharmaceutical Antacid Product
Table 119. Takeda Pharmaceutical Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Pfizer Antacid Product
Table 124. Pfizer Recent Development
Table 125. Reckitt Benckiser Corporation Information
Table 126. Reckitt Benckiser Description and Business Overview
Table 127. Reckitt Benckiser Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Reckitt Benckiser Antacid Product
Table 129. Reckitt Benckiser Recent Development
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Bayer Antacid Product
Table 134. Bayer Recent Development
Table 135. Procter＆Gamble Corporation Information
Table 136. Procter＆Gamble Description and Business Overview
Table 137. Procter＆Gamble Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Procter＆Gamble Antacid Product
Table 139. Procter＆Gamble Recent Development
Table 140. GlaxoSmithKline Corporation Information
Table 141. GlaxoSmithKline Description and Business Overview
Table 142. GlaxoSmithKline Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. GlaxoSmithKline Antacid Product
Table 144. GlaxoSmithKline Recent Development
Table 145. Johnson＆Johnson Corporation Information
Table 146. Johnson＆Johnson Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Johnson＆Johnson Description and Business Overview
Table 148. Johnson＆Johnson Antacid Product
Table 149. Johnson＆Johnson Recent Development
Table 150. CONBA Corporation Information
Table 151. CONBA Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. CONBA Description and Business Overview
Table 153. CONBA Antacid Product
Table 154. CONBA Recent Development
Table 155. Xiuzheng Pharma Corporation Information
Table 156. Xiuzheng Pharma Description and Business Overview
Table 157. Xiuzheng Pharma Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Xiuzheng Pharma Antacid Product
Table 159. Xiuzheng Pharma Recent Development
Table 160. Sanofi Corporation Information
Table 161. Sanofi Description and Business Overview
Table 162. Sanofi Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Sanofi Antacid Product
Table 164. Sanofi Recent Development
Table 165. Bausch Health Corporation Information
Table 166. Bausch Health Description and Business Overview
Table 167. Bausch Health Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Bausch Health Antacid Product
Table 169. Bausch Health Recent Development
Table 170. CR SANJIU Corporation Information
Table 171. CR SANJIU Description and Business Overview
Table 172. CR SANJIU Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. CR SANJIU Antacid Product
Table 174. CR SANJIU Recent Development
Table 175. Reddy's Laboratories Corporation Information
Table 176. Reddy's Laboratories Description and Business Overview
Table 177. Reddy's Laboratories Antacid Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Reddy's Laboratories Antacid Product
Table 179. Reddy's Laboratories Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Antacid Distributors List
Table 183. Antacid Customers List
Table 184. Antacid Market Trends
Table 185. Antacid Market Drivers
Table 186. Antacid Market Challenges
Table 187. Antacid Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Antacid Product Picture
Figure 2. Global Antacid Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antacid Sales Market Share by Application in 2021 & 2027
Figure 6. OTC Drug Examples
Figure 7. Rx Drug Examples
Figure 8. Global Antacid Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Antacid Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Antacid Sales (M Units) Growth Rate (2016-2027)
Figure 11. Global Antacid Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Antacid Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Antacid Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Antacid Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Antacid Sales (M Units) Growth Rate (2016-2027)
Figure 16. Europe Antacid Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Antacid Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Antacid Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Antacid Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Antacid Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Antacid Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Antacid Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Antacid Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Antacid Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Antacid Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Antacid Players Market Share by Revenue in Antacid: 2016 & 2020
Figure 27. Antacid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Antacid Revenue Share by Type (2016-2021)
Figure 29. Global Antacid Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Antacid Revenue Share by Application (2016-2021)
Figure 31. Global Antacid Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Antacid Sales Market Share by Type in 2020
Figure 33. North America Antacid Sales Market Share by Application in 2020
Figure 34. Europe Antacid Sales Market Share by Type in 2020
Figure 35. Europe Antacid Sales Market Share by Application in 2020
Figure 36. China Antacid Sales Market Share by Type in 2020
Figure 37. China Antacid Sales Market Share by Application in 2020
Figure 38. Japan Antacid Sales Market Share by Type in 2020
Figure 39. Japan Antacid Sales Market Share by Application in 2020
Figure 40. Southeast Asia Antacid Sales Market Share by Type in 2020
Figure 41. Southeast Asia Antacid Sales Market Share by Application in 2020
Figure 42. India Antacid Sales Market Share by Type in 2020
Figure 43. India Antacid Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Antacid
Figure 46. Manufacturing Process Analysis of Antacid
Figure 47. Antacid Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
プロトンポンプ阻害薬のグローバル市場調査 2019年 The global Proton Pump Inhibitor Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proton Pump Inhibitor Drug volume and value at global level, regional level and company level. From a global per…- プロトンポンプ阻害薬のグローバル市場調査 2019年 The global Proton Pump Inhibitor Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Proton Pump Inhibitor Drug volume and value at global level, regional level and company level. From a global per…
- ナルコレプシー治療薬のグローバル市場2021 Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss o…
- 抗体薬物複合体（ADC）のグローバル市場2021 Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…
- バイオシミラー薬のグローバル市場2021 Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or a…